Type of hormone therapy and risk of misclassification at mammography screening

Sisse Helle Njor, Jesper Hallas, Walter Schwartz, Elsebeth Lynge, Anette Tønnes Pedersen

9 Citationer (Scopus)

Abstrakt

Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.
OriginalsprogEngelsk
TidsskriftMenopause (New York, N.Y.)
Vol/bind18
Udgave nummer2
Sider (fra-til)171-7
Antal sider7
DOI
StatusUdgivet - 1 feb. 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Type of hormone therapy and risk of misclassification at mammography screening'. Sammen danner de et unikt fingeraftryk.

Citationsformater